Effect of carbogen breathing on the pharmacodynamics of 5-fluorouracil in a murine colon carcinoma

European Journal of Cancer

Volumn 36, Issue 9, 2000, Pages 1180-1186

  Kamm, Y J L ^a   Heerschap, A ^a   Wagener, D J Th ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

5 Fluorouracil; 19F NMR spectroscopy; Carbogen

Indexed keywords

CARBOGEN; FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG METABOLISM; DRUG RETENTION; DRUG UPTAKE; FEMALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGENATION; PHARMACODYNAMICS; PRIORITY JOURNAL; TUMOR GROWTH;

ADMINISTRATION, INHALATION; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CARBON DIOXIDE; COLONIC NEOPLASMS; FEMALE; FLUOROURACIL; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED C57BL; OXYGEN;

EID: 0034029750     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00063-0     Document Type: Article

References (24)

1. Kemeny N., Lokich J.J., Anderson N., Ahlgren J.D. Recent advances in the treatment of advanced colorectal cancer. Cancer. 71:1993;9-18.
2. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J. Natl. Cancer Inst. 88:1996;252-258.
3. Rougier P., Paillot B., Laplanche A.et al. 5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer. Eur. J. Cancer. 33:1997;1789-1793.
4. Kamm Y.J.L., Rietjens I.M.C.M., Vervoort J.et al. Effect of modulators on 5-fluorouracil metabolite patterns in murine colon carcinoma determined by in vitro 19F nuclear magnetic resonance spectroscopy. Cancer Res. 54:1994;4321-4326.
5. Kruuv J.A., Inch W.R., McCredie J.A. Blood flow and oxygenation of tumors in mice. II. Effects of vasodilator drugs. Cancer. 20:1967;60-65.
6. Howe F.A., Robinson S.P., Rodrigues L.M., Griffiths J.R. Flow and oxygenation dependent (flood) contrast MR imaging to monitor the response of rat tumors to carbogen breathing. Magnet. Reson. Imag. 17:1999;1307-1318.
7. Stubbs M., Robinson S.P., Rodrigues L.M., Parkins C.S., Collingridge D.R., Griffiths J.R. The effects of host carbogen (95% oxygen/5% carbon dioxide) breathing on metabolic characteristics of Morris hepatoma 9618a. Br. J. Cancer. 78:1998;1449-1456.
8. van der Sanden B.P.J., Heerschap A., Hoofd L.et al. Effect of carbogen breathing on the physiological profile of human glioma xenografts. Magnet. Reson. Med. 42:1999;490-499.
9. Kaanders J.H., Pop L.A., Marres H.A., van der Maazen R.W., van der Kogel A.J., van Daal W.A. Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer. feasibility and toxicity Radiother. Oncol. 37:1995;190-198.
10. Teicher B.A. Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapy. Artif. Cells Blood Substit. Immobil. Biotechnol. 22:1994;1109-1120.
11. Kim G.E., Song C.W. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo. Cancer Chemother. Pharmacol. 25:1989;99-102.
12. Rodrigues L.M., Maxwell R.J., McSheehy P.M.et al. In vivo detection of ifosfamide by 31P-MRS in rat tumours. increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas Br. J. Cancer. 75:1997;62-68.
13. McSheehy P.M., Robinson S.P., Ojugo A.S.et al. Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors. a magnetic resonance study in vivo Cancer Res. 58:1998;1185-1194.
14. Guerquin Kern J.L., Leteurtre F., Croisy A., Lhoste J.M. pH dependence of 5-fluorouracil uptake observed by in vivo 31P and 19F nuclear magnetic resonance spectroscopy. Cancer Res. 51:1991;5770-5773.
15. Peters G.J., Van Dijk J., Nadal J.C., van Groeningen C.J., Lankelma J., Pinedo H.M. Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer. In Vivo. 1:1987;113-117.
16. Blijham G.H. Chemotherapy of colorectal cancer. Anticancer Drugs. 2:1991;233-245.
17. Guichard M., Lartigau E., Martin L.et al. Tumor oxygenation after (1) carbogen and/or perflubron emulsion administration in tumor xenografts; (2) carbogen administration in patients. Artif. Cells Blood Substit. Immobil. Biotechnol. 22:1994;1355-1360.
18. Martin L., Lartigau E., Weeger P.et al. Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother. Oncol. 27:1993;123-130.
19. van der Veen J.W., de Beer R., Luyten P.R., van Ormondt D. Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge. Magnet. Reson. Med. 6:1988;92-98.
20. van den Boogaart A., Howe F.A., Rodrigues L.M., Stubbs M., Griffiths J.R. In vivo 31P MRS. absolute concentrations, signal-to-noise and prior knowledge NMR Biomed. 8:1995;87-93.
21. Rijken P.F., Bernsen H.J., van der Kogel A.J. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc. Res. 50:1995;141-153.
22. Presant C.A., Wolf W., Waluch V.et al. Association of intratumoral pharmacokinetics of fluorouracil with clinical response [see comments]. Lancet. 343:1994;1184-1187.
23. Thomas C.D., Stern S., Chaplin D.J., Guichard M. Transient perfusion and radiosensitizing effect after nicotinamide, carbogen, and perflubron emulsion administration. Radiother. Oncol. 39:1996;235-241.
24. 19F nuclear magnetic resonance spectroscopy pharmacokinetics J. Clin. Oncol. 8:1990;1868-1873.